1834 Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2M | Sell |
4,760
-37
| -0.8% | -$7.96K | 0.14% | 115 |
|
|
2026
Q1 | $1.04M | Sell |
4,797
-129
| -3% | -$28.6K | 0.13% | 109 |
|
|
2025
Q4 | $1.13M | Sell |
4,926
-128
| -3% | -$29.2K | 0.14% | 108 |
|
|
2025
Q3 | $1.17M | Sell |
5,054
-435
| -8% | -$88.6K | 0.14% | 103 |
|
|
2025
Q2 | $1.02M | Hold |
5,489
| – | – | 0.13% | 109 |
|
|
2025
Q1 | $1.15M | Sell |
5,489
-3,990
| -42% | -$776K | 0.15% | 100 |
|
|
2024
Q4 | $1.68M | Sell |
9,479
-562
| -6% | -$103K | 0.21% | 89 |
|
|
2024
Q3 | $1.98M | Sell |
10,041
-8,513
| -46% | -$1.59M | 0.23% | 86 |
|
|
2024
Q2 | $3.18M | Sell |
18,554
-33,920
| -65% | -$5.62M | 0.38% | 70 |
|
|
2024
Q1 | $9.56M | Sell |
52,474
-25,702
| -33% | -$4.43M | 1.14% | 18 |
|
|
2023
Q4 | $12.1M | Sell |
78,176
-9,299
| -11% | -$1.36M | 1.45% | 12 |
|
|
2023
Q3 | $13M | Buy |
87,475
+2,276
| +3% | +$334K | 1.62% | 11 |
|
|
2023
Q2 | $11.5M | Buy |
85,199
+41,546
| +95% | +$6.09M | 1.37% | 14 |
|
|
2023
Q1 | $6.96M | Buy |
43,653
+27,204
| +165% | +$4.16M | 0.83% | 34 |
|
|
2022
Q4 | $2.66M | Sell |
16,449
-1,055
| -6% | -$162K | 0.38% | 65 |
|
|
2022
Q3 | $2.35M | Buy |
17,504
+5,394
| +45% | +$774K | 0.35% | 65 |
|
|
2022
Q2 | $1.85M | Sell |
12,110
-4,870
| -29% | -$744K | 0.26% | 70 |
|
|
2022
Q1 | $2.75M | Sell |
16,980
-79,590
| -82% | -$11.6M | 0.34% | 64 |
|
|
2021
Q4 | $13.1M | Buy |
96,570
+2,863
| +3% | +$338K | 1.48% | 18 |
|
|
2021
Q3 | $10.1M | Buy |
93,707
+4,251
| +5% | +$486K | 1.23% | 26 |
|
|
2021
Q2 | $10.1M | Buy |
89,456
+3,754
| +4% | +$423K | 1.22% | 29 |
|
|
2021
Q1 | $9.28M | Buy |
85,702
+6,336
| +8% | +$678K | 1.2% | 29 |
|
|
2020
Q4 | $8.5M | Buy |
79,366
+6,978
| +10% | +$671K | 1.13% | 32 |
|
|
2020
Q3 | $6.34M | Buy |
72,388
+3,440
| +5% | +$324K | 0.92% | 39 |
|
|
2020
Q2 | $6.77M | Buy |
68,948
+6,365
| +10% | +$560K | 1.07% | 35 |
|
|
2020
Q1 | $4.77M | Buy |
62,583
+57,798
| +1,208% | +$4.92M | 0.91% | 37 |
|
|
2019
Q4 | $424K | Sell |
4,785
-280
| -6% | -$23.2K | 0.07% | 128 |
|
|
2019
Q3 | $384K | Sell |
5,065
-1,635
| -24% | -$112K | 0.06% | 135 |
|
|
2019
Q2 | $488K | Sell |
6,700
-777
| -10% | -$61.1K | 0.07% | 117 |
|
|
2019
Q1 | $603K | Buy |
7,477
+97
| +1% | +$7.93K | 0.09% | 110 |
|
|
2018
Q4 | $680K | Sell |
7,380
-491
| -6% | -$43.2K | 0.11% | 108 |
|
|
2018
Q3 | $744K | Sell |
7,871
-68,875
| -90% | -$6.53M | 0.11% | 109 |
|
|
2018
Q2 | $7.11M | Buy |
76,746
+42,752
| +126% | +$4.18M | 1.11% | 36 |
|
|
2018
Q1 | $3.22M | Sell |
33,994
-76,796
| -69% | -$8.44M | 0.55% | 56 |
|
|
2017
Q4 | $10.7M | Buy |
110,790
+60
| +0.1% | +$5.66K | 1.69% | 12 |
|
|
2017
Q3 | $9.84M | Sell |
110,730
-13,794
| -11% | -$1.05M | 1.84% | 12 |
|
|
2017
Q2 | $9.03M | Sell |
124,524
-4,095
| -3% | -$275K | 1.7% | 11 |
|
|
2017
Q1 | $8.38M | Sell |
128,619
-585
| -0.5% | -$36.8K | 1.61% | 14 |
|
|
2016
Q4 | $8.09M | Buy |
129,204
+8,292
| +7% | +$506K | 1.63% | 16 |
|
|
2016
Q3 | $7.63M | Buy |
120,912
+2,048
| +2% | +$133K | 1.66% | 16 |
|
|
2016
Q2 | $7.36M | Buy |
118,864
+2,129
| +2% | +$130K | 1.6% | 15 |
|
|
2016
Q1 | $6.67M | Buy |
116,735
+10,282
| +10% | +$573K | 1.52% | 16 |
|
|
2015
Q4 | $6.31M | Buy |
106,453
+854
| +0.8% | +$49.2K | 1.48% | 18 |
|
|
2015
Q3 | $5.75M | Buy |
105,599
+6,580
| +7% | +$428K | 1.43% | 18 |
|
|
2015
Q2 | $6.65M | Buy |
99,019
+2,262
| +2% | +$148K | 1.82% | 11 |
|
|
2015
Q1 | $5.66M | Buy |
96,757
+3,221
| +3% | +$195K | 1.54% | 19 |
|
|
2014
Q4 | $6.12M | Buy |
93,536
+19,154
| +26% | +$1.21M | 1.69% | 13 |
|
|
2014
Q3 | $4.3M | Buy |
74,382
+58,673
| +373% | +$3.26M | 1.18% | 34 |
|
|
2014
Q2 | $887K | Buy |
15,709
+837
| +6% | +$43.9K | 0.24% | 88 |
|
|
2014
Q1 | $764K | Sell |
14,872
-752
| -5% | -$38K | 0.22% | 90 |
|
|
2013
Q4 | $825K | Sell |
15,624
-620
| -4% | -$30.5K | 0.24% | 88 |
|
|
2013
Q3 | $727K | Sell |
16,244
-628
| -4% | -$27.8K | 0.24% | 83 |
|
|
2013
Q2 | $698K | Buy |
+16,872
| New | +$738K | 0.24% | 89 |
|
Other funds holding ABBV
1834 Investment Advisors's ABBV Position: Q2 2026 in Review
1834 Investment Advisors reduced its AbbVie (ABBV) stake by 0.77% in Q2 2026, selling an estimated $7.96K and leaving 4,760 shares worth $1.2M. The position accounts for 0.14% of the portfolio, ranked #115.
1834 Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.1M in Q4 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- 1834 Investment Advisors held 4,760 shares of AbbVie worth $1.2M as of Q2 2026.
- 1834 Investment Advisors sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
- AbbVie made up 0.14% of 1834 Investment Advisors's portfolio in Q2 2026, its #115 holding.
- 1834 Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1834 Investment Advisors's AbbVie position peaked at $13.1M in Q4 2021.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on 1834 Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.